Close

GSK (GSK) Says FDA Committee Endorsed Effectiveness, Safety of Single-dose Tafenoquine for P. vivax Malaria

July 12, 2018 5:31 PM EDT Send to a Friend
GSK (NYSE: GSK) and Medicines for Malaria Venture (MMV) today announced that the Antimicrobial Drugs Advisory Committee (AMDAC) of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login